浙江医学
浙江醫學
절강의학
ZHEJIANG MEDICAL JOURNAL
2014年
3期
175-177,160
,共4页
高燕红%罗群%蔡珂丹%邬民香
高燕紅%囉群%蔡珂丹%鄔民香
고연홍%라군%채가단%오민향
糖尿病肾病%帕立骨化醇%肾素%前列腺素E2%环氧化酶- 2
糖尿病腎病%帕立骨化醇%腎素%前列腺素E2%環氧化酶- 2
당뇨병신병%파립골화순%신소%전렬선소E2%배양화매- 2
Diabetic nephropathy%Paricalcitol%Renin%Prostaglandin E2%Cyclooxygenase- 2
目的探讨帕立骨化醇对糖尿病肾病(DN)大鼠的肾保护作用及其可能机制。方法采用腹腔内注射链脲佐菌素(STZ)构建DN大鼠模型。将造模成功的大鼠随机分为帕立骨化醇组(P组)、DN组(D组),并设置健康对照组(N组)。P组大鼠每周腹腔注射帕立骨化醇3次,剂量为0.4μg/kg,给药12周后检测24h尿蛋白定量及血生化指标,以实时PCR检测肾组织肾素及环氧化酶-2(COX-2)mRNA表达,免疫组化检测肾组织COX-2蛋白的表达,并以ELISA法检测尿前列腺素E2(PGE2)水平。结果与N组相比,D组与P组24h尿蛋白定量、血肌酐(SCr)、空腹血糖及甲状旁腺激素(PTH)均显著升高(均P<0.05),肾组织肾素和COX-2 mRNA及蛋白表达,以及尿PGE2水平均显著升高(均P<0.05),且D组显著高于P组(P<0.05)。肾素水平与尿PGE2水平及COX-2 mRNA表达均呈正相关(r=0.798、0.722,均P<0.01)。结论帕立骨化醇可显著减少DN大鼠早期蛋白尿,其机制可能与通过抑制肾组织COX-2表达,下调尿PGE2水平,从而抑制肾组织肾素表达有关。
目的探討帕立骨化醇對糖尿病腎病(DN)大鼠的腎保護作用及其可能機製。方法採用腹腔內註射鏈脲佐菌素(STZ)構建DN大鼠模型。將造模成功的大鼠隨機分為帕立骨化醇組(P組)、DN組(D組),併設置健康對照組(N組)。P組大鼠每週腹腔註射帕立骨化醇3次,劑量為0.4μg/kg,給藥12週後檢測24h尿蛋白定量及血生化指標,以實時PCR檢測腎組織腎素及環氧化酶-2(COX-2)mRNA錶達,免疫組化檢測腎組織COX-2蛋白的錶達,併以ELISA法檢測尿前列腺素E2(PGE2)水平。結果與N組相比,D組與P組24h尿蛋白定量、血肌酐(SCr)、空腹血糖及甲狀徬腺激素(PTH)均顯著升高(均P<0.05),腎組織腎素和COX-2 mRNA及蛋白錶達,以及尿PGE2水平均顯著升高(均P<0.05),且D組顯著高于P組(P<0.05)。腎素水平與尿PGE2水平及COX-2 mRNA錶達均呈正相關(r=0.798、0.722,均P<0.01)。結論帕立骨化醇可顯著減少DN大鼠早期蛋白尿,其機製可能與通過抑製腎組織COX-2錶達,下調尿PGE2水平,從而抑製腎組織腎素錶達有關。
목적탐토파립골화순대당뇨병신병(DN)대서적신보호작용급기가능궤제。방법채용복강내주사련뇨좌균소(STZ)구건DN대서모형。장조모성공적대서수궤분위파립골화순조(P조)、DN조(D조),병설치건강대조조(N조)。P조대서매주복강주사파립골화순3차,제량위0.4μg/kg,급약12주후검측24h뇨단백정량급혈생화지표,이실시PCR검측신조직신소급배양화매-2(COX-2)mRNA표체,면역조화검측신조직COX-2단백적표체,병이ELISA법검측뇨전렬선소E2(PGE2)수평。결과여N조상비,D조여P조24h뇨단백정량、혈기항(SCr)、공복혈당급갑상방선격소(PTH)균현저승고(균P<0.05),신조직신소화COX-2 mRNA급단백표체,이급뇨PGE2수평균현저승고(균P<0.05),차D조현저고우P조(P<0.05)。신소수평여뇨PGE2수평급COX-2 mRNA표체균정정상관(r=0.798、0.722,균P<0.01)。결론파립골화순가현저감소DN대서조기단백뇨,기궤제가능여통과억제신조직COX-2표체,하조뇨PGE2수평,종이억제신조직신소표체유관。
Objective To investigate the renoprotective effect of paricalcitol in rats with diabetic nephropathy (DN) and its mechanism. Methods Diabetic nephropathy was induced by intraperitoneal injection of streptozotocin in rats. The DN rats were randomly divided into DN group (group D) and paricalcitol group (group P), rats in group P were intraperitonealy injected with 0.4μg/kg paricalcitol t.i.w. Healthy non- DN rats served as control group (group N). After 12 weeks, 24h urinary protein and serum biochemical indicators were examined. Real- time PCR were used to detect expression of renin mRNA and cyclooxygenase- 2 (COX- 2) in renal tissue. Immunohistochemistry was used to detect the protein expression of COX- 2. ELISA method was used to detect the urine levels of prostaglandin E2 (PGE2). Results Compared to group N, 24- h urinary protein, serum creatinine(SCr), fasting blood glucose(FBG) and parathyroid hormone(PTH) levels and urinary PGE2 levels were significantly increased (P<0.05) in groups D and P;the expression of renin mRNA, COX- 2 mRNA and protein in renal tissue of groups D and P were also signifi-cantly increased (P<0.05). The above indexes of group D were markedly higher than those of group P (P<0.05). The renin level was positively correlated with urinary PGE2 (r=0.798, P<0.01) and COX- 2 mRNA expression (r=0.722, P<0.01). Conclusion Paricalcitol can significantly reduce the proteinuria in rats with diabetic nephropathy, which may be associated with down- regu-lation of COX- 2, PGE2 and renin expression.